Hyundai Mobis Co. has come up with an in-house brainwave-based driver monitoring system that can reduce the risk of drowsy driving by up to one-third.
The system, dubbed M.Brain, is a wearable earpiece that continuously detects and analyzes drivers' brain activity.
The company has examined the actual effect of the technology through a pilot study on public buses in Gyeonggi Province over the past year in partnership with the Gyeonggi Research Institute.
According to the findings, drivers who used M.Brain saw their risk of careless driving during after-meal hours, when drowsy driving is most common, drop by up to 30 percent.
M.Brain helped minimize the danger of careless driving by roughly 20% on highways where drowsy driving can lead to multi-car accidents.
When sloppy driving was detected in real-time, the device helped drivers recover attention within 2.3 seconds by blasting an alarm over the speakers and vibrating the seat.
This is nearly three times faster than the 6.7 seconds it took non-M.Brain drivers to regain attention.


US Plans Kenya Ebola Quarantine Facility Amid Congo Outbreak
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
CDC Monitors U.S. Travelers After Hantavirus Outbreak on Luxury Cruise Ship
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Trump Signs Executive Order to Boost AI Research in Childhood Cancer
Alphabet Replaces Verizon in Dow Jones Industrial Average
Tesla and NatPower Partner on $5 Billion Battery Storage Expansion in Europe
OpenAI May Delay IPO to 2027 Amid $1 Trillion Valuation Goal
NASA's Artemis II Crew Arrives in Florida for Historic Moon Mission
Blue Origin New Glenn Rocket Explodes During Launch Pad Test, Delaying Space Ambitions
Apple Supplier Stocks Slide as Samsung, SK Hynix Lead Selloff After Apple Price Hikes
Kioxia Targets U.S. Listing as AI Chip Boom Accelerates
AstraZeneca Q1 2026 Earnings Surge on Strong Oncology and Rare Disease Drug Sales
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
White House Seeks $1.4 Billion to Combat Growing Ebola Outbreak
Neuralink Expands Brain Implant Trials with 12 Global Patients 



